HomeKLRA • NASDAQ
add
Kailera Therapeutics Inc
Previous close
$16.00
Day range
$23.70 - $27.50
Year range
$23.70 - $27.50
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 158.34M | 545.78% |
Net income | -148.96M | 54.80% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -158.03M | -546.62% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 546.06M | 211.71% |
Total assets | 692.29M | 287.96% |
Total liabilities | 56.39M | 715.92% |
Total equity | 635.91M | — |
Shares outstanding | 19.05K | — |
Price to book | -0.00 | — |
Return on assets | -22.73% | — |
Return on capital | -24.18% | — |
Cash Flow
Net change in cash
| (USD) | 2025info | Y/Y change |
|---|---|---|
Net income | -148.96M | 54.80% |
Cash from operations | -120.21M | 35.01% |
Cash from investing | -492.60M | -125,243.26% |
Cash from financing | 598.66M | 33.60% |
Net change in cash | -14.15M | -105.38% |
Free cash flow | -59.89M | — |
About
Founded
2024
Website
Employees
145
